ARCHIVES

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

Addendum to RAID

December 17, 1999

NCI Would Fund 3,164 research Project Grants, 897 Competition, Under FY92 While House Budget

February 15, 1991

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003